Critical Care

official impact factor 4.60

Letter

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view

Stylianos Karatzas1*, Eleni Boutzouka1, Kyriaki Venetsanou2, Pavlos Myrianthefs3, George Fildisis1 and George Baltopoulos4

Author Affiliations

1 Attending Physician, Athens University School of Nursing ICU at KAT Hospital, Greece

2 Chemist, Research Unit, Athens University School of Nursing ICU at KAT Hospital, Greece

3 Research Fellow, Northwestern University Department of Critical Care and Pulmonary Diseases, Chicago, Illinois, USA

4 Professor and Director of Athens University School of Nursing ICU at KAT Hospital, Greece

For all author emails, please log on.

Critical Care 2002, 6:543-544 doi:10.1186/cc1837

Published: 24 October 2002

First paragraph (this article has no abstract)

We read with interest the paper by Tugrul et al. [1] regarding the effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis managed in their intensive care unit. Apart from the global interest of reading a paper in the field of the treatment of severe sepsis and septic shock, we have an almost similar project in progress.